U.S., Feb. 7 -- An application to own the trademark for 'CYTEGRITY' has been filed on Jun. 24, 2024.
Owner(s):
CSL Behring Gene Therapy, Inc.; 35 N. Lake Avenue, Suite 650, California
Goods and/or Services:
For: Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare
Class(es): 100, 101, 102
For: Custom manufacture of pharmaceuticals based on cell therapy and gene therapy; Custom manufacture of medicine, namely, personalized medicine for others based on unique characteristics and conditions of the patient
Class(es): 100, 103, 106
For: Research and development services relating to viral vectors, cell therapies, gene therapies, and medicines; Development of pharmaceutical ...